FDA Flags Higher Death Rates Linked to Use of Abiomed Heart Pump in Post-approval Study

FDA Flags Higher Death Rates Linked to Use of Abiomed Heart Pump in Post-approval Study

Source: 
RAPS.org
snippet: 

A temporary heart pump manufactured by Massachusetts-based Abiomed prompted a US Food and Drug Administration letter to health care providers on Monday over an increased rate of mortality.